Global Antibody Drug Conjugate Market is Projected to Grow $9.93 Billion by 2025


Free Press Release DB | Press Release Date : May 17, 2019  Download


The global antibody drug conjugates market size was valued at USD 1.57 billion in 2017 and is projected to register a CAGR of 25.9% over the forecast period.


The global Antibody Drug Conjugate Market size is expected to reach USD 9.93 billion by 2025, according to a new report by Grand View Research, Inc. it is projected to expand at a CAGR of 25.9% over the forecast period. Increasing incidence of cancer coupled with growing geriatric population are likely to drive the market for Antibody-Drug Conjugates (ADC). Furthermore, major technological advancements are also contributing to drive the growth. According to the World Health Organization (WHO), the number of people aged 65 years and above, is projected to reach 16% of the total population by 2050 from 7% in 2000. Aging has become a substantial risk factor for numerous diseases including cancer and others. Hence, the growing geriatric population is expected to drive growth of the market over the forecast period.

Until 2018, four ADCs were available in the market, namely, Adcetris, Kadcyla, Besponsa, and Mylotarg. Due to appropriate targeting and improved technology, ADCs have been gaining a lot of attention from both small and large pharmaceutical companies. Currently there are more than 50 ADCs in clinical trials and it has been projected that during the forecast period three to four ADCs will be commercialized in the area of refractory Hodgkin lymphoma, glioblastoma, small cell lung cancer, breast cancer, and ovarian cancer. It has been observed that the maximum number of clinical trials are being conducted for lymphoma.

Seattle Genetics and Roche are leading the antibody drug conjugate market in terms of market share. Until 2017 only two ADCs were commercially available-Adcetris by Seattle Genetics and Kadcyla by Roche. Recently, two more Pfizer’s products were approved to be marketed for acute myeloid leukaemia and acute lymphoblastic leukaemia. Hence, it has been estimated that over the forecast period, Pfizer is anticipated to gain a significant market share.

Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/antibody-drug-conjugates-market

Further key findings from the report suggest:

Grand View Research has segmented the global antibody drug conjugate market on the basis of application, technology, and region:

Antibody Drug Conjugate Application Outlook (Revenue, USD Million, 2014 - 2025)

Antibody Drug Conjugate Technology Outlook (Revenue, USD Million, 2014 - 2025)

Antibody Drug Conjugate Regional Outlook (Revenue, USD Million, 2014 - 2025)




Contact Person & Company

Name

:

Carrol Topp

Company

:

Grand View Research, Inc.

Contact Numbers

Telephone No.

:

Fax No.

:

Handphone No.

:

Website

Website 1

:

Website 2

:

Youtube

:

PR Tags

:

Antibody Drug Conjugates Market,

Address


Contact The Author



Contact Carrol Topp






More Press Release From Author



Global Aminoglycosides Market Size, Growth | Industry Report, 2022


Free Press Release DB :

Aminoglycosides Market Analysis By Drug (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin), By Mode of Administration (Feed, Injectables (Parenteral), Intra-mammary, Topical, Oral) --> Read This Press Release !



By : Carrol, Topp ( Jun 20, 2019 )
Category : Healthcare Press Release | Country : United States Press Release




Global Biosensors Market to Reach USD 21.2 Billion by 2020 | Grand View Research


Free Press Release DB :

Biosensors Market Size, Share & Trends Analysis Report By Application (Medical, Agriculture) By Technology (Thermal, Electrochemical, Optical) And Segment Forecasts, 2012 - 2020 --> Read This Press Release !



By : Carrol, Topp ( Jun 19, 2019 )
Category : Healthcare Press Release | Country : United States Press Release




Veterinary Pain Management Market to Reach USD1.73 Billion by 2026 | Grand View Research


Free Press Release DB :

Veterinary Pain Management Market Size, Share & Trends Analysis Report By Product (NSAIDs, Anesthetics), By Indication, By Animal Type (Companion, Livestock), By End Use, And Segment Forecasts, 2019 - 2026 --> Read This Press Release !



By : Carrol, Topp ( Jun 18, 2019 )
Category : Healthcare Press Release | Country : United States Press Release





Read More Articles From Carrol Topp



Disclaimer

The author of the press releases are solely responsible for the content of their press releases. Freepressreleasedb.com can't be held liable for the content posted by author. Please check the accuracy of the press release before using the press release. If necessary please contact the author. Thank you.




Report Abuse